Cyclacel Pharmaceuticals, Inc.
CYCC
$0.23
-$0.0152-6.20%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -49.83% | -40.97% | -75.53% | -81.59% | -74.93% |
| Total Receivables | -50.61% | -50.13% | -78.04% | -37.11% | -9.46% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -45.95% | -56.31% | -60.22% | -18.85% | -44.55% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -84.15% | -86.28% | -38.66% | -19.95% | 1,047.06% |
| Total Current Assets | -55.79% | -49.61% | -74.52% | -69.51% | -60.19% |
|
|
|||||
| Total Current Assets | -55.79% | -49.61% | -74.52% | -69.51% | -60.19% |
| Net Property, Plant & Equipment | -56.00% | -52.70% | -49.41% | -41.38% | -34.21% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -67.20% | -58.70% | -57.34% | -63.67% | -56.82% |
| Total Assets | -56.94% | -50.19% | -72.05% | -68.61% | -59.71% |
|
|
|||||
| Total Accounts Payable | 162.64% | 118.58% | 107.25% | 38.34% | 59.82% |
| Total Accrued Expenses | -69.57% | -52.80% | -38.04% | -8.35% | 94.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -6.74% | 68.80% | 32.74% | 16.56% | 106.98% |
| Total Other Current Liabilities | -6.74% | 68.80% | 32.74% | 16.56% | 106.98% |
| Total Current Liabilities | -22.05% | 6.52% | 13.79% | 8.65% | 87.18% |
|
|
|||||
| Total Current Liabilities | -22.05% | 6.52% | 13.79% | 8.65% | 87.18% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -92.42% | -73.75% | -65.09% | -51.40% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -22.55% | -36.40% | -29.73% | -32.31% | -8.42% |
|
|
|||||
| Common Stock & APIC | 1.87% | 3.01% | 1.56% | 1.61% | 1.40% |
| Retained Earnings | -3.18% | -4.09% | -4.68% | -5.56% | -6.09% |
| Treasury Stock & Other | 11.56% | 16.59% | 26.63% | 31.00% | 33.10% |
| Total Common Equity | -122.57% | -80.55% | -121.74% | -96.19% | -80.53% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -122.57% | -80.55% | -121.74% | -96.19% | -80.53% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -122.57% | -80.55% | -121.74% | -96.19% | -80.53% |
|
|
|||||
